| Activated oncogenic pathways and therapeutic targets in extranodal nasal‐type NK/T cell lymphoma revealed by gene expression profiling SB Ng, V Selvarajan, G Huang, J Zhou, AL Feldman, M Law, YL Kwong, ... The Journal of pathology 223 (4), 496-510, 2011 | 168 | 2011 |
| EZH2 overexpression in natural killer/T-cell lymphoma confers growth advantage independently of histone methyltransferase activity J Yan, SB Ng, JLS Tay, B Lin, TL Koh, J Tan, V Selvarajan, SC Liu, C Bi, ... Blood, The Journal of the American Society of Hematology 121 (22), 4512-4520, 2013 | 167 | 2013 |
| EZH2 phosphorylation by JAK3 mediates a switch to noncanonical function in natural killer/T-cell lymphoma J Yan, B Li, B Lin, PT Lee, TH Chung, J Tan, C Bi, XT Lee, V Selvarajan, ... Blood, The Journal of the American Society of Hematology 128 (7), 948-958, 2016 | 137 | 2016 |
| Dysregulated microRNAs affect pathways and targets of biologic relevance in nasal-type natural killer/T-cell lymphoma SB Ng, J Yan, G Huang, V Selvarajan, JLS Tay, B Lin, C Bi, J Tan, ... Blood, The Journal of the American Society of Hematology 118 (18), 4919-4929, 2011 | 120 | 2011 |
| Epstein-Barr virus-associated primary nodal T/NK-cell lymphoma shows a distinct molecular signature and copy number changes SB Ng, TH Chung, S Kato, S Nakamura, E Takahashi, YH Ko, JD Khoury, ... Haematologica 103 (2), 278, 2018 | 104 | 2018 |
| T-cell death following immune activation is mediated by mitochondria-localized SARM P Panneerselvam, LP Singh, V Selvarajan, WJ Chng, SB Ng, NS Tan, ... Cell Death & Differentiation 20 (3), 478-489, 2013 | 89 | 2013 |
| PXR pharmacogenetics: association of haplotypes with hepatic CYP3A4 and ABCB1 messenger RNA expression and doxorubicin clearance in Asian breast cancer patients E Sandanaraj, S Lal, V Selvarajan, LL Ooi, ZW Wong, NS Wong, PCS Ang, ... Clinical Cancer Research 14 (21), 7116-7126, 2008 | 84 | 2008 |
| RUNX3 is oncogenic in natural killer/T-cell lymphoma and is transcriptionally regulated by MYC V Selvarajan, M Osato, GSS Nah, J Yan, TH Chung, DCC Voon, Y Ito, ... Leukemia 31 (10), 2219-2227, 2017 | 68 | 2017 |
| Determinants of response to daratumumab in Epstein-Barr virus-positive natural killer and T-cell lymphoma N Mustafa, AHF Nee, JY Chooi, SHM Toh, TH Chung, V Selvarajan, S Fan, ... Journal for Immunotherapy of Cancer 9 (7), 2021 | 11 | 2021 |
| Prognostic implication of morphology, cyclinE2 and proliferation in EBV-associated T/NK lymphoproliferative disease in non-immunocompromised hosts SB Ng, K Ohshima, V Selvarajan, G Huang, SN Choo, H Miyoshi, S Wang, ... Orphanet Journal of Rare Diseases 9, 1-11, 2014 | 11 | 2014 |
| Epstein–Barr virus-associated T/natural killer-cell lymphoproliferative disorder in children and young adults has similar molecular signature to extranodal nasal natural killer … SB Ng, K Ohshima, V Selvarajan, G Huang, SN Choo, H Miyoshi, ... Leukemia & Lymphoma 56 (8), 2408-2415, 2015 | 9 | 2015 |
| CD55 and CD59 can limit the anti-tumor efficacy of daratumumab in natural killer/T-cell lymphoma N Mustafa, AHF Nee, JY Chooi, SHM Toh, YT Hee, V Selvarajan, L Zhou, ... Blood 132, 1663, 2018 | 4 | 2018 |
| T and NK cell lymphoma cell lines do not rely on ZAP-70 for survival S de Mel, N Mustafa, V Selvarajan, MI Azaman, PW Jaynes, ... Plos one 17 (1), e0261469, 2022 | 1 | 2022 |
| Effect of IL-2 and IL-7/IL-15 concentration on t cell expansion V Selvarajan, G How, D Teo, W Loh, B Loo Cytotherapy 23 (5), S177-S177, 2021 | 1 | 2021 |
| Expanding T-cells using stirred-tank and a novel biaxial rotary bioreactor V Selvarajan, A Wong, W Loh, Y Ng, C Nge, PT Lau, G Khoo, B Loo Cytotherapy 22 (5), S152-S153, 2020 | 1 | 2020 |
| Piloting a scale-up platform for high-quality human T-cells production V Selvarajan, DBL Teo, CC Chang, YL Ng, N Cheong, J Sivalingam, ... Frontiers in Cell and Developmental Biology 12, 1427171, 2024 | | 2024 |
| EBV‐ASSOCIATED NODAL T AND NK‐CELL LYMPHOMA SHOWS DISTINCT MOLECULAR SIGNATURE AND COPY NUMBER CHANGES WJ Chng, TH Chung, V Selvarajan, SB Ng Hematological Oncology 35, 122-122, 2017 | | 2017 |
| Characterization of the Biological and Clinical Relevance of RUNX Genes in Natural Killer/T-Cell Lymphoma V Selvarajan PQDT-Global, 2016 | | 2016 |
| T-cell death following immune activation is mediated by mitochondria-localized SARM B Ho, J Chen, LP Singh, V Selvarajan, SB Ng, NS Tan, P Panneerselvam, ... | | 2013 |
| EZH2 Is Aberrantly Expressed and Plays a Pro-Proliferative Role Independent of Its Methyltransferase Activity in Natural Killer/T-Cell Lymphoma WJ Chng, J Yan, NG Siok-Bian, J Tay, B Lin, TL Koh, J Tan, V Selvarajan, ... Blood 120 (21), 3498, 2012 | | 2012 |
